Form 4: Achieve Life Sciences CFO Receives Stock Grant
Insider Transaction (Form 4)
Benjamin Halladay, Chief Financial Officer of Achieve Life Sciences, Inc., reported multiple transactions in common stock on October 5, 2026.
Summary
- Grant/award: acquired 200,000 Stock Option (right to buy) on October 5, 2026; holds 200,000 after (Direct).
- Grant/award: acquired 200,000 Restricted Stock Unit (RSU) on October 5, 2026; holds 200,000 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Benjamin Halladay — Officer (Chief Financial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-05 | Grant/award | Stock Option (right to buy) | 200,000 | — | — | 200,000 |
| 2026-10-05 | Grant/award | Restricted Stock Unit (RSU) | 200,000 | — | — | 200,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-05 | Grant/award (200,000 shares) |
| 2026-10-05 | Grant/award (200,000 shares) |
Keywords
insider transaction, Form 4, ACHV, ACHIEVE LIFE SCIENCES, INC., neutral, Benjamin Halladay
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.